409 related articles for article (PubMed ID: 30428290)
1. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
Meintjes G; Stek C; Blumenthal L; Thienemann F; Schutz C; Buyze J; Ravinetto R; van Loen H; Nair A; Jackson A; Colebunders R; Maartens G; Wilkinson RJ; Lynen L;
N Engl J Med; 2018 Nov; 379(20):1915-1925. PubMed ID: 30428290
[TBL] [Abstract][Full Text] [Related]
2. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
Naidoo K; Yende-Zuma N; Padayatchi N; Naidoo K; Jithoo N; Nair G; Bamber S; Gengiah S; El-Sadr WM; Friedland G; Abdool Karim S
Ann Intern Med; 2012 Sep; 157(5):313-24. PubMed ID: 22944873
[TBL] [Abstract][Full Text] [Related]
3. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
Havlir DV; Kendall MA; Ive P; Kumwenda J; Swindells S; Qasba SS; Luetkemeyer AF; Hogg E; Rooney JF; Wu X; Hosseinipour MC; Lalloo U; Veloso VG; Some FF; Kumarasamy N; Padayatchi N; Santos BR; Reid S; Hakim J; Mohapi L; Mugyenyi P; Sanchez J; Lama JR; Pape JW; Sanchez A; Asmelash A; Moko E; Sawe F; Andersen J; Sanne I;
N Engl J Med; 2011 Oct; 365(16):1482-91. PubMed ID: 22010914
[TBL] [Abstract][Full Text] [Related]
4. Integration of antiretroviral therapy with tuberculosis treatment.
Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray AL; Gengiah T; Gengiah S; Naidoo A; Jithoo N; Nair G; El-Sadr WM; Friedland G; Abdool Karim Q
N Engl J Med; 2011 Oct; 365(16):1492-501. PubMed ID: 22010915
[TBL] [Abstract][Full Text] [Related]
5. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.
Blanc FX; Sok T; Laureillard D; Borand L; Rekacewicz C; Nerrienet E; Madec Y; Marcy O; Chan S; Prak N; Kim C; Lak KK; Hak C; Dim B; Sin CI; Sun S; Guillard B; Sar B; Vong S; Fernandez M; Fox L; Delfraissy JF; Goldfeld AE;
N Engl J Med; 2011 Oct; 365(16):1471-81. PubMed ID: 22010913
[TBL] [Abstract][Full Text] [Related]
6. Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial).
Stek C; Schutz C; Blumenthal L; Thienemann F; Buyze J; Nöstlinger C; Ravinetto R; Wouters E; Colebunders R; Maartens G; Wilkinson RJ; Lynen L; Meintjes G
JMIR Res Protoc; 2016 Aug; 5(3):e173. PubMed ID: 27571786
[TBL] [Abstract][Full Text] [Related]
7. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients.
Dibyendu D; Sarkar RN; Phaujdar S; Bhattacharyya K; Pal HK
Braz J Infect Dis; 2011; 15(6):553-9. PubMed ID: 22218514
[TBL] [Abstract][Full Text] [Related]
9. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome.
Meintjes G; Wilkinson RJ; Morroni C; Pepper DJ; Rebe K; Rangaka MX; Oni T; Maartens G
AIDS; 2010 Sep; 24(15):2381-90. PubMed ID: 20808204
[TBL] [Abstract][Full Text] [Related]
10. Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome.
Bonnet M; Baudin E; Jani IV; Nunes E; Verhoustraten F; Calmy A; Bastos R; Bhatt NB; Michon C
PLoS One; 2013; 8(12):e84585. PubMed ID: 24367678
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in initiating ART among HIV-Infected patients in China-risk factors and management.
Yang H; Liu Q; Wu Y; He K; Zeng Q; Liu M
BMC Infect Dis; 2024 Jan; 24(1):5. PubMed ID: 38166781
[TBL] [Abstract][Full Text] [Related]
12. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction.
Narendran G; Andrade BB; Porter BO; Chandrasekhar C; Venkatesan P; Menon PA; Subramanian S; Anbalagan S; Bhavani KP; Sekar S; Padmapriyadarshini C; Kumar S; Ravichandran N; Raja K; Bhanu K; Mahilmaran A; Sekar L; Sher A; Sereti I; Swaminathan S
PLoS One; 2013; 8(5):e63541. PubMed ID: 23691062
[TBL] [Abstract][Full Text] [Related]
15. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome.
Marais S; Meintjes G; Pepper DJ; Dodd LE; Schutz C; Ismail Z; Wilkinson KA; Wilkinson RJ
Clin Infect Dis; 2013 Feb; 56(3):450-60. PubMed ID: 23097584
[TBL] [Abstract][Full Text] [Related]
16. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
[TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
[TBL] [Abstract][Full Text] [Related]
18. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.
Blanc FX; Badje AD; Bonnet M; Gabillard D; Messou E; Muzoora C; Samreth S; Nguyen BD; Borand L; Domergue A; Rapoud D; Natukunda N; Thai S; Juchet S; Eholié SP; Lawn SD; Domoua SK; Anglaret X; Laureillard D;
N Engl J Med; 2020 Jun; 382(25):2397-2410. PubMed ID: 32558469
[TBL] [Abstract][Full Text] [Related]
19. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.
Severe P; Juste MA; Ambroise A; Eliacin L; Marchand C; Apollon S; Edwards A; Bang H; Nicotera J; Godfrey C; Gulick RM; Johnson WD; Pape JW; Fitzgerald DW
N Engl J Med; 2010 Jul; 363(3):257-65. PubMed ID: 20647201
[TBL] [Abstract][Full Text] [Related]
20. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.
Haddow LJ; Moosa MY; Mosam A; Moodley P; Parboosing R; Easterbrook PJ
PLoS One; 2012; 7(11):e40623. PubMed ID: 23152745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
